1590361-11-7

Basic information

• Product Name: O-diethylcarbamoyl-N-phenethylhydroxylamine
• Synonyms: O-diethylcarbamoyl-N-phenethylhydroxylamine
• CAS NO: 1590361-11-7
• Molecular Weight: 236.314
• Mol File: 1590361-11-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: O-diethylcarbamoyl-N-phenethylhydroxylamine(CAS DataBase Reference)
• NIST Chemistry Reference: O-diethylcarbamoyl-N-phenethylhydroxylamine(1590361-11-7)
• EPA Substance Registry System: O-diethylcarbamoyl-N-phenethylhydroxylamine(1590361-11-7)

Safety Data

• Hazardous Substances Data: 1590361-11-7(Hazardous Substances Data)

Upstream product

• 1310367-01-1 N-tert-butoxycarbonyl-O-diethylcarbamoylhydroxylamine 
• 103-63-9 1-phenyl-2-bromoethane 
• 1590361-13-9 O-benzoyl-N-tert-butoxycarbonyl-N-phenethylhydroxylamine 
• 1590361-20-8 N-tert-butoxycarbonyl-O-diethylcarbamoyl-N-phenethylhydroxylamine 

Downstream Products

• 33799-96-1 N-(2-phenylethyl)-4-fluorobenzamide 
• 1590361-28-6 C₂₅H₃₁N₃O₃S 
• 1590361-34-4 (E)-2-((4-(dimethylamino)phenyl)diazenyl)-N-(3-(4-(phenethylcarbamoyl)phenoxy)propyl)benzamide 
• 551908-65-7 4-fluoro-N-(3-phenylpropyl)-benzamide 
• 38925-70-1 N-(2-phenylethyl)-o-chlorobenzamide 
• 38925-71-2 β-(m-chlorbenzamido)ethylbenzol 
• 75690-78-7 N-(2-phenylethyl)thiophene-2-carboxamide 
• 72213-27-5 N-Phthalyl-L-phenylalanyl-2-phenylethylamin 
• 10264-26-3 N-(2-phenylethyl)hexanamide 
• 3278-14-6 N-phenethylbenzamide 
• 38925-77-8 4-methyl-N-(2-phenylethyl)benzamide 
• 324546-94-3 4-(tert-butyl)-N-phenethylbenzamide 
• 6346-07-2 4-methoxy-N-(2-phenylethyl)benzamide 
• 328931-56-2 4-bromo-N-(2-phenylethyl)benzamide 

Relevant articles and documents

Chemoselective Amide-Forming Ligation Between Acylsilanes and Hydroxylamines Under Aqueous Conditions

We report the facile amide-forming ligation of acylsilanes with hydroxylamines (ASHA ligation) under aqueous conditions. The ligation is fast, chemoselective, mild, high-yielding and displays excellent functional-group tolerance. Late-stage modifications of an array of marketed drugs, peptides, natural products, and biologically active compounds showcase the robustness and functional-group tolerance of the reaction. The key to the success of the reaction could be the possible formation of the strong Si?O bond via a Brook-type rearrangement. Given its simplicity and efficiency, this ligation has the potential to unfold new applications in the areas of medicinal chemistry and chemical biology.